Selective accumulation and growth inhibition of hybrid liposomes to human hepatocellular carcinoma cells in relation to fluidity of plasma membranes

Biochemical and Biophysical Research Communications

Volumn 418, Issue 1, 2012, Pages 81-86

  Komizu, Yuji ^a   Ueoka, Hidetsugu ^a   Ueoka, Ryuichi ^a  

^a SOJO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Hepatocellular carcinoma; Hybrid liposomes; Membrane fluidity

Indexed keywords

CASPASE 3; DIMYRISTOYLPHOSPHATIDYLCHOLINE; HYBRID LIPOSOME; LIPOSOME; POLIDOCANOL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOACCUMULATION; CANCER INHIBITION; CARCINOMA CELL; CELL MEMBRANE; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; DRUG ACCUMULATION; ENZYME ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TARGET CELL; TARGET CELL DESTRUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; DIMYRISTOYLPHOSPHATIDYLCHOLINE; HUMANS; LIPOSOMES; LIVER NEOPLASMS; MEMBRANE FLUIDITY; NANOPARTICLES; POLYETHYLENE GLYCOLS;

EID: 84856499494     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.134     Document Type: Article

References (37)

1. Sethi N., Kang Y. Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat. Rev. Cancer 2011, 11:735-748.
2. Suresh S. Biomechanics and biophysics of cancer cells. Acta Biomater. 2007, 3:5.
3. Cross S.E., Jin Y.S., Rao J., Gimzewski J.K. Nanomechanical analysis of cells from cancer patients. Nat. Nanotech. 2007, 2:780-783.
4. Iyer S., Gaikwad R.M., Subba-Rao V., Woodworth C.D., Sokolov I. AFM detects differences in the surface brush of normal and cancerous cervical cells. Nat. Nanotech. 2009, 4:389-393.
5. Jiang J., Nilsson-Ehle1 P., Xu N. Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis. 2006, 5:1-7.
6. Van Blitterswijk W.J., De Veer G., Krol J.H., Emmelot P. Comparative lipid analysis of purified plasma membranes and shed extracellular membrane vesicles from normal murine thymocytes and leukemic GRSL cells. Biochim. Biophys. Acta 1982, 688:495-504.
7. Shinitzky M. Membrane fluidity in malignancy. Adversative and recuperative. Biochim. Biophys. Acta 1984, 738:251-261.
8. Hendrich A.B., Michalak K. Lipids as a target for drugs modulating multidrug resistance of cancer cells. Curr. Drug Targets 2003, 4:23-30.
9. Inbar M., Shinitzky M. Cholesterol as a bioregulator in the development and inhibition of leukemia. Proc. Natl. Acad. Sci. USA 1974, 71:4229-4231.
10. Liebes L.F., Pelle E., Zucker-Franklin D., Silber R. Comparison of lipid composition and 1,6-diphenyl-1,3,5-hexatriene fluorescence polarization measurements of hairy cells with monocytes and lymphocytes from normal subjects and patients with chronic lymphocytic leukemia. Cancer Res. 1981, 41:4050-4056.
11. Baker C.J., Bowler K. Lipid composition of the membranes from cells of two rat tumors and its relationship to tumor thermosensitivity. Radiat. Res. 1991, 125:48-55.
12. Batko J., Potast-Necas B., Rosenbaum S.M., Naparstek E., Shouval D., Inbar M. The effect of an experimental neoplastic disease on the flux of sodium and potassium ions across red blood cells and on the lipid composition of their membranes. Acta Biochim. Pol. 1992, 39:317-326.
13. Qi Z., Sun L., Liu J. Dynamic parameter of membrane lipid in lung cancer cell lines, carcinogenesis cells and cancer cells isolated from patients with lung cancer. Chin. J. Cancer Res. 1991, 3:24-30.
14. Yukihara M., Komizu Y., Tanoue O., Matsushita T., Matsumoto Y., Ueoka R. Specific accumulation and antitumor effects of hybrid liposomes on the growth of lung tumor cells. Yakugaku Zasshi 2010, 130:1581-1587.
15. Sok, Šentjurc M., Schara M., Stare J., Rott T. Cell membrane fluidity and prognosis of lung cancer. Ann. Thorac. Surg. 2002, 73:1567-1571.
16. Funaki N., Tanaka J., Kono Y., Nonaka A., Yotsumoto F., Lee J.-U., Imamura M. Combination of R-fetoprotein mRNA-based detection of hematogenously disseminating hepatocellular carcinoma cells and analysis of cancer cell membrane fluidity is more accurate in screening patients at risk of postoperative recurrence. Oncol. Rep. 2004, 11:637-639.
17. Taraboletti G., Perin L., Bottazzi B., Mantovani A., Giavazzi R., Salmona M. Membrane fluidity affects tumor-cell motility, invasion and lung-colonizing potential. Int. J. Cancer 1989, 44:707-713.
18. Zeisig R., Koklič T., Wiesner B., Fichtner I., Sentjurč M. Increase in fluidity in the membrane of MT3 breast cancer cells correlates with enhanced cell adhesion in vitro and increased lung metastasis in NOD/SCID mice. Archi. Biochem. Biophys. 2007, 459:98-106.
19. Gonda K., Watanabe T.M., Ohuchi N., Higuchi H. In vivo nano-imaging of membrane dynamics in metastatic tumor cells using quantum dots. J. Biol. Chem. 2010, 285:2750-2757.
20. Baselga J. Targeting tyrosine kinases in cancer: the second wave. Science 2006, 312:1175-1178.
21. Noble M.E.M., Endicott J.A., Johnson L.N. Protein kinase inhibitors: insights into drug design from structure. Science 2004, 303:1800-1805.
22. Ueoka R., Moss R.A., Swarup S., Matsumoto Y., Strauss G., Murakami Y. Extraordinary micellar enantioselectivity coupled to altered aggregate structure. J. Am. Chem. Soc. 1985, 107:2185-2186.
23. Ueoka R., Matsumoto Y., Moss R.A., Swarup S., Sugii A., Harada K., Kikuchi J., Murakami Y. Membrane matrix for the hydrolysis of amino acid esters with marked enantioselectivity. J. Am. Chem. Soc. 1988, 110:1588-1595.
24. Kitamura I., Kochi M., Matsumoto Y., Ueoka R., Kuratsu J., Ushio Y. Intrathecal chemotherapy with l,3-bis(2-chloroethyl)-l-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study. Cancer Res. 1996, 56:3986-3992.
25. Matsumoto Y., Iwamoto Y., Matsushita T., Ueoka R. Novel mechanism of hybrid liposomes-induced apoptosis in human tumor cells. Int. J. Cancer 2005, 115:377-382.
26. Nakano K., Iwamoto Y., Takata W., Matsumoto Y., Ueoka R. Specific accumulation and growth inhibitory effects of hybrid liposomes to hepatoma cells in vitro. Bioorg. Med. Chem. Lett. 2002, 12:3251-3254.
27. Komizu Y., Matsumoto Y., Ueoka R. Membrane targeted chemotherapy with hybrid liposomes for colon tumor cells leading to apoptosis. Bioorg. Med. Chem. Lett. 2006, 16:6131-6134.
28. Ichihara H., Ueno J., Umebayashi M., Matsumoto Y., Ueoka R. Chemotherapy with hybrid liposomes for acute lymphatic leukemia leading to apoptosis in vivo. Int. J. Pharm. 2011, 406:173-178.
29. Ueoka R., Matsumoto Y., Goto K., Ichihara H., Komizu Y. Membrane targeted chemotherapy with hybrid liposomes for tumor cells leading to apoptosis. Curr. Pharm. Des. 2011, 17:1709-1719.
30. Ichihara H., Nagami H., Kiyokawa T., Matsumoto Y., Ueoka R. Chemotherapy using hybrid liposomes along with induction of apoptosis. Anticancer Res. 2008, 28:1187-1195.
31. Komizu Y., Nakata S., Goto K., Matsumoto Y., Ueoka R. Membrane-targeted nanotherapy with hybrid liposomes for tumor cells leading to apoptosis. ACS Med. Chem. Lett. 2011, 2:275-279.
32. Komizu Y., Yukihara M., Kariya R., Goto K., Okada S., Ueoka R. Selective accumulation of hybrid liposomes into adult T-cell leukemia cells along with induction of apoptosis. Bioorg. Med. Chem. Lett. 2011, 21:3962-3965.
33. Nakabayashi H., Taketa K., Miyano K., Yamane T., Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 1982, 42:3858-3863.
34. Axelrod D. Total internal reflection fluorescence microscopy. Meth. Cell. Biol. 1989, 30:245-270.
35. Towata T., Komizu Y., Suzu S., Okada S., Ueoka R. Highly selective fusion and accumulation of hybrid liposomes into primary effusion lymphoma cells along with induction of apoptosis. Biophys. Biochem. Res. Comun. 2010, 393:445-448.
36. 1 phase. Bioorg. Med. Chem. Lett. 2010, 20:3680-3682.
37. Papahadjopoulos D., Poste G., Schaeffer B.E. Fusion of mammalian cells by unlamellar lipid vesicles: influence of lipid surface charge, fluidity and cholesterol. Biochim. Biophys. Acta 1973, 323:23-42.